Search Results 131-140 of 18516 for Relapse
The purpose of this study is to determine the maximum tolerated dose (MTD) of SAR442085 administered as a single agent in patients with relapsed or ...
... relapse and developing treatment strategies to reduce sleep disruption and minimize relapse risk. In addition, Dr. Kolla is actively involved in education ...
ROCHESTER, Minn. — Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T-cell therapy, ...
Relapsed subjects including first and second relapse. AML relapse > 6 months since autologous or allogeneic stem cell transplantation, provided they are in ...
"With regain of weight, individuals experience relapse of weight-related medical comorbidities, thus contributing once more to socio-economic and direct health ...
Clinical Trials · A study of how current treatments impact the course of relapsed myeloma and the effect of the treatments on the quality-of-life measurements.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.